CD9 and cancer: In general, the EV levels of CD9, CD81 and CD151 were increased in OC and B samples compared with Ctrl and PD samples (Fig 4 B-D), which could be due to samples being obtained from two different biobanks, but increased levels of EVs have previously been reported in cancer patients [24,25].